Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer. Suzuki M, Takenaka Y, Kishikawa T, Yamamoto Y, et al. Anticancer Res 2021;41:2045-2051.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suzuki M, Takenaka Y, Kishikawa T, Yamamoto Y, et al. Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer. Anticancer Res 2021;41:2045-2051.
PMID: 33813412